Terms/Glossary

Skriv ut

News Archive

7 October 2008
Oral anticancer drug CP-4126 enters Clinical Phase I study

15 September 2008
Promising Clinical Phase I results for Intravenous CP-4126 presented at ESMO

22 August 2008
Clinical development of ELACYT in haematology expanded

29 July 2008
ELACYT Clinical Update

25 June 2008
Clavis Pharma receives US Orphan Drug Designation for ELACYT

25 June 2008
Promising Results for Oral CP-4126

2 June 2008
ELACYT™ clinical results presented at ASCO

30 May 2008
Clavis Pharma ASA to present Phase I clinical results from ELACYT in patients with cancers of the blood

24 April 2008
Clavis Pharma's First Quarter results

3 April 2008
Clavis Pharma starts ELACYT phase II study in haematology